U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive - CTV News

U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive – CTV News

April 25, 2026

U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV NewsTrump psychedelics order largely symbolic, analysts say The GuardianFDA grants quick review for 3 psychedelic drug trials NBC NewsTrump orders more access to psychedelics like LSD, psilocybin and ibogaine The Washington PostColorado experts and advocates discuss ibogaine’s potential, risks as lawmakers weigh bill to research its use CBS News